1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Wang, G.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
51
653
664
10.1021/bi2016266
22185690
Structure, Dynamics, and Antimicrobial and Immune Modulatory Activities of Human LL-23 and Its Single-Residue Variants Mutated on the Basis of Homologous Primate Cathelicidins.
2012
10.2210/pdb2lmf/pdb
pdb_00002lmf
2831.405
Antibacterial protein LL-37
UNP residues 134-156
1
syn
polymer
Cathelicidin antimicrobial peptide
no
no
LLGDFFRKSKEKIGKEFKRIVQR
LLGDFFRKSKEKIGKEFKRIVQR
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_database_status
pdbx_nmr_software
repository
Initial release
Database references
Data collection
Database references
Other
1
0
2011-12-28
1
1
2012-02-08
1
2
2023-06-14
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.status_code_nmr_data
_pdbx_nmr_software.name
LL-37
BMRB
Y
RCSB
2011-11-30
REL
REL
REL
REL
9606
human
Homo sapiens
sample
structures with the lowest energy
100
20
2D 1H-15N HSQC
2D 1H-13C HSQC aliphatic
2D 1H-1H NOESY
2D 1H-1H TOCSY
2D DQF-COSY
2D 1H-13C HSQC aromatic
2
mM
unbuffered
6
ambient
310
K
simulated annealing
1
lowest energy
2 mM LL, 100% D2O
100% D2O
Schwieters, Kuszewski, Tjandra and Clore
structure solution
X-PLOR NIH
Schwieters, Kuszewski, Tjandra and Clore
refinement
X-PLOR NIH
600
Varian
INOVA
Varian INOVA
400
Bruker
DMX
Bruker DMX
LEU
1
n
1
LEU
1
A
LEU
2
n
2
LEU
2
A
GLY
3
n
3
GLY
3
A
ASP
4
n
4
ASP
4
A
PHE
5
n
5
PHE
5
A
PHE
6
n
6
PHE
6
A
ARG
7
n
7
ARG
7
A
LYS
8
n
8
LYS
8
A
SER
9
n
9
SER
9
A
LYS
10
n
10
LYS
10
A
GLU
11
n
11
GLU
11
A
LYS
12
n
12
LYS
12
A
ILE
13
n
13
ILE
13
A
GLY
14
n
14
GLY
14
A
LYS
15
n
15
LYS
15
A
GLU
16
n
16
GLU
16
A
PHE
17
n
17
PHE
17
A
LYS
18
n
18
LYS
18
A
ARG
19
n
19
ARG
19
A
ILE
20
n
20
ILE
20
A
VAL
21
n
21
VAL
21
A
GLN
22
n
22
GLN
22
A
ARG
23
n
23
ARG
23
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
A
O
H
ILE
PHE
13
17
1.37
1
A
A
O
H
PHE
LYS
6
10
1.40
1
A
A
O
H
SER
ILE
9
13
1.57
2
A
A
O
H
ILE
PHE
13
17
1.32
2
A
A
O
H
PHE
LYS
6
10
1.36
2
A
A
O
H
GLU
ILE
16
20
1.46
2
A
A
O
H
LEU
PHE
2
5
1.60
3
A
A
O
H
ILE
PHE
13
17
1.33
3
A
A
O
H
PHE
LYS
6
10
1.43
3
A
A
O
H
LEU
PHE
2
5
1.52
3
A
A
O
H
SER
ILE
9
13
1.52
4
A
A
O
H
ILE
PHE
13
17
1.32
4
A
A
O
H
PHE
LYS
6
10
1.39
4
A
A
O
H
LEU
PHE
2
5
1.54
4
A
A
O
H
PHE
VAL
17
21
1.59
5
A
A
O
H
ILE
PHE
13
17
1.35
5
A
A
O
H
PHE
LYS
6
10
1.42
5
A
A
O
H
LEU
PHE
2
5
1.49
6
A
A
O
H
ILE
PHE
13
17
1.32
6
A
A
O
H
PHE
LYS
6
10
1.41
6
A
A
O
H
SER
ILE
9
13
1.55
6
A
A
O
H
LEU
PHE
2
5
1.59
7
A
A
O
H
ILE
PHE
13
17
1.31
7
A
A
O
H
PHE
LYS
6
10
1.44
7
A
A
O
H
GLU
ILE
16
20
1.53
7
A
A
O
H
LEU
PHE
2
5
1.54
8
A
A
O
H
ILE
PHE
13
17
1.32
8
A
A
O
H
PHE
LYS
6
10
1.39
8
A
A
O
H
LEU
PHE
2
5
1.50
9
A
A
O
H
PHE
LYS
6
10
1.34
9
A
A
O
H
ILE
PHE
13
17
1.36
9
A
A
O
H
PHE
VAL
17
21
1.44
9
A
A
O
H
LEU
PHE
2
5
1.57
10
A
A
O
H
ILE
PHE
13
17
1.37
10
A
A
O
H
PHE
LYS
6
10
1.42
11
A
A
O
H
ILE
PHE
13
17
1.33
11
A
A
O
H
PHE
LYS
6
10
1.40
11
A
A
O
H
GLU
ILE
16
20
1.55
11
A
A
O
H
LEU
PHE
2
5
1.55
12
A
A
O
H
ILE
PHE
13
17
1.36
12
A
A
O
H
PHE
LYS
6
10
1.48
12
A
A
O
H
LYS
GLY
10
14
1.51
13
A
A
O
H
ILE
PHE
13
17
1.32
13
A
A
O
H
PHE
LYS
6
10
1.35
13
A
A
O
H
LEU
PHE
2
5
1.56
13
A
A
O
H
SER
ILE
9
13
1.59
14
A
A
O
H
ILE
PHE
13
17
1.33
14
A
A
O
H
PHE
LYS
6
10
1.40
14
A
A
O
H
LEU
PHE
2
5
1.51
14
A
A
O
H
GLU
ILE
16
20
1.52
14
A
A
O
H
SER
ILE
9
13
1.59
15
A
A
O
H
ILE
PHE
13
17
1.33
15
A
A
O
H
PHE
LYS
6
10
1.44
15
A
A
O
H
LEU
PHE
2
5
1.53
15
A
A
O
H
LYS
GLY
10
14
1.59
16
A
A
O
H
ILE
PHE
13
17
1.37
16
A
A
O
H
PHE
LYS
6
10
1.45
17
A
A
O
H
PHE
LYS
6
10
1.39
17
A
A
O
H
ILE
PHE
13
17
1.45
17
A
A
O
H
LEU
PHE
2
5
1.47
18
A
A
O
H
ILE
PHE
13
17
1.34
18
A
A
O
H
PHE
LYS
6
10
1.41
19
A
A
O
H
PHE
LYS
6
10
1.32
19
A
A
O
H
ILE
PHE
13
17
1.39
20
A
A
O
H
ILE
PHE
13
17
1.32
20
A
A
O
H
PHE
LYS
6
10
1.35
20
A
A
O
H
VAL
ARG
21
23
1.56
20
A
A
O
H
PHE
VAL
17
21
1.59
1
A
VAL
21
-93.90
44.83
1
A
GLN
22
-62.82
77.74
3
A
VAL
21
-114.98
70.88
5
A
VAL
21
-98.23
53.16
6
A
VAL
21
-84.20
37.49
6
A
GLN
22
-43.75
88.78
7
A
GLN
22
21.68
35.92
8
A
VAL
21
-112.83
69.30
9
A
GLN
22
-66.99
64.62
10
A
VAL
21
-85.76
30.37
10
A
GLN
22
28.68
60.16
11
A
VAL
21
-105.03
55.46
11
A
GLN
22
-63.15
88.54
12
A
GLN
22
-156.96
15.59
14
A
GLN
22
-5.52
73.90
15
A
VAL
21
-116.66
65.56
16
A
VAL
21
-82.09
35.26
16
A
GLN
22
-43.04
89.02
17
A
GLN
22
-63.28
69.00
18
A
GLN
22
-39.08
83.74
19
A
GLN
22
-49.16
87.51
20
A
VAL
21
-96.65
54.69
20
A
GLN
22
-68.23
43.02
lowest energy, model 20
Solution structure of human LL-23 bound to membrane-mimetic micelles
1
N
N
A
LEU
1
A
LEU
1
HELX_P
A
VAL
21
A
VAL
21
1
1
21
ANTIMICROBIAL PROTEIN
antimicrobial and innate immune modulating peptide, ANTIMICROBIAL PROTEIN
CAMP_HUMAN
UNP
1
134
P49913
LLGDFFRKSKEKIGKEFKRIVQR
134
156
2LMF
1
23
P49913
A
1
1
23